Walleye Capital LLC Vericel Corp Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $2.7 Million - $3.35 Million	85,288 New	85,288 $2.86 Million
Q2 2021 Aug 16, 2021	SELL	$47.2 - $67.81 $615,393 - $884,106	-13,038 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$30.93 - $59.48 $403,265 - $775,500	13,038 New	13,038 $724,000
Q4 2020 Feb 16, 2021	SELL	$18.53 - $31.5 $232,329 - $394,947	-12,538 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.68 - $19.12 $184,057 - $239,726	12,538 New	12,538 $232,000
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $2,175 - $5,766	-300 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.77 - $19.2 $4,131 - $5,760	300 New	300 $5,000

275

48.7M

85.9K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.49B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.